News & Updates

Some antihypertensive medications may lower dementia risk

24 Jan 2023 by

Use of angiotensin II (ATII)-stimulating antihypertensive medication (AHM), angiotensin receptor blockers (ARBs), and dihydropyridine calcium channel blockers (CCBs) helps reduce the risk of dementia over a decade, but this beneficial effect decreases over time, according to a study.

Some antihypertensive medications may lower dementia risk

24 Jan 2023

Traction-assisted ESD speeds up resection of colorectal tumour

24 Jan 2023

Use of a traction device for endoscopic submucosal dissection (ESD) using a scissor-type knife in the proximal colon and for large lesions helps expedite resection in patients with superficial colorectal tumour, a study has shown.

Traction-assisted ESD speeds up resection of colorectal tumour

24 Jan 2023

Multiple factors contribute to sleep troubles in middle-aged Asian women

24 Jan 2023 by

More than a third of women in Singapore have difficulty sleeping, according to a study. Factors such as education level, irritability, vaginal dryness, disability, urinary incontinence, and breast cancer history contribute to poor sleep quality, the magnitude of which varying by ethnicity.

Multiple factors contribute to sleep troubles in middle-aged Asian women

24 Jan 2023

Bladder cycling pretransplant offers no clinical advantage in patients with defunctionalized bladder

24 Jan 2023

For patients with defunctionalized bladder, bladder cycling prior to renal transplant does little to improve outcomes such as postoperative urological complication, urodynamic criteria, and graft function and survival, according to a study.

Bladder cycling pretransplant offers no clinical advantage in patients with defunctionalized bladder

24 Jan 2023

Efgartigimod tied to sustained platelet count increase in patients with ITP

24 Jan 2023 by

Treatment with efgartigimod, a neonatal Fc receptor (FcRn) antagonist, in patients with chronic or persistent immune thrombocytopenia (ITP) resulted in a higher proportion of patients achieving a sustained platelet count response compared with placebo, according to the ADVANCE IV* trial presented at ASH 2022.

Efgartigimod tied to sustained platelet count increase in patients with ITP

24 Jan 2023

Finerenone reduces SBP in diabetic patients with CKD

23 Jan 2023

Treatment with finerenone, a selective nonsteroidal mineralocorticoid receptor antagonist with a short half-life, results in decreased 24-h, daytime, and night-time systolic blood pressure (SBP), results of a study have shown.

Finerenone reduces SBP in diabetic patients with CKD

23 Jan 2023

Objective response to systemic therapy linked to overall survival in unresectable HCC

23 Jan 2023 by

Objective response to first-line systemic therapy with lenvatinib or sorafenib independently predicts overall survival (OS) in individuals with unresectable hepatocellular carcinoma (HCC), as shown by the subanalysis of the REFLECT study.

Objective response to systemic therapy linked to overall survival in unresectable HCC

23 Jan 2023

Higher HCQ dose ups incident retinopathy risk

23 Jan 2023

A recent study reports an overall risk of 8.6 percent for hydroxychloroquine (HCQ) retinopathy after 15 years in a large cohort with active surveillance retinopathy screening. Notably, most of these cases are mild, and a higher HCQ dose appears to result in progressively greater risk for incident retinopathy.

Higher HCQ dose ups incident retinopathy risk

23 Jan 2023

Infections a risk factor for dementia

23 Jan 2023

Individuals who have been hospitalized with infection appear to be at higher risk of dementia compared with their peers who are unexposed to infections, as reported in a study.

Infections a risk factor for dementia

23 Jan 2023

Device filters out direct thrombin inhibitor from plasma for routine haemostasis tests

23 Jan 2023 by

A user-friendly medical device can effectively remove the direct thrombin inhibitor (DTI) argatroban from plasma in a rapid and ergonomic manner, as shown in the results of a study presented at ASH 2022.

Device filters out direct thrombin inhibitor from plasma for routine haemostasis tests

23 Jan 2023

News & Updates

Filter by Specialty:

Specialty:

Some antihypertensive medications may lower dementia risk

Some antihypertensive medications may lower dementia risk

Traction-assisted ESD speeds up resection of colorectal tumour

Traction-assisted ESD speeds up resection of colorectal tumour

Multiple factors contribute to sleep troubles in middle-aged Asian women

Multiple factors contribute to sleep troubles in middle-aged Asian women

Bladder cycling pretransplant offers no clinical advantage in patients with defunctionalized bladder

Bladder cycling pretransplant offers no clinical advantage in patients with defunctionalized bladder

Efgartigimod tied to sustained platelet count increase in patients with ITP

Efgartigimod tied to sustained platelet count increase in patients with ITP

Finerenone reduces SBP in diabetic patients with CKD

Finerenone reduces SBP in diabetic patients with CKD

Objective response to systemic therapy linked to overall survival in unresectable HCC

Objective response to systemic therapy linked to overall survival in unresectable HCC

Higher HCQ dose ups incident retinopathy risk

Higher HCQ dose ups incident retinopathy risk

Infections a risk factor for dementia

Infections a risk factor for dementia

Device filters out direct thrombin inhibitor from plasma for routine haemostasis tests

Device filters out direct thrombin inhibitor from plasma for routine haemostasis tests